Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Troponin T Assay Allows Earlier Detection of Myocardial Injury

By LabMedica International staff writers
Posted on 27 Oct 2009
A sensitive diagnostic assay has been developed to improve the detection and exclusion of myocardial injury in the early stages and to help identify risk of future coronary events.

Called the Elecsys Troponin T high sensitive (TnT hs) assay, it detects 0.003 ng/mL - 10 ng/mL Troponin T in serum or plasma. More...
The assay will be used on cobas and Modular Analytics serum work areas, in the United Kingdom and Ireland.

Launched by Roche (Burgess Hill, UK), Elecsys TnT hs is a commercially available assay, which not only meets the precision requirements (<10% coefficient of variation at the 99th percentile of the reference range) set down in the American College of Cardiology/European Society of Cardiology (ACC/ESC) and National Academy of Clinical Biochemistry/Academy of the American Association for Clinical Chemistry (NACB/AACC) definition of myocardial infarction, but also demonstrates the best level of assay designation (= 95% measurable normal values below the 99th percentile).

In addition, in a recent comparative evaluation, Elecsys TnT hs displayed the highest sensitivity (95 %) and negative predictive value (99%) in the diagnosis of unstable angina at presentation. This sensitivity and precision make the Elecsys TnT hs assay a valuable and much needed tool for the early detection and exclusion of acute myocardial infarction (AMI).

The Elecsys TnT hs assay is further indicated for the risk stratification of patients presenting with acute coronary syndrome (particularly in the risk assessment of chronic renal failure patients), providing a valuable aid in the selection of patients who may require more intensive therapy and intervention.

The robustness of the Elecsys TnT hs assay against interfering factors ensures accuracy and consistency in patient follow-up, and the availability of a STAT (9 min) version for rapid results delivers rapid turnaround time for emergency samples.

The cardiac portfolio from Roche offers the combination of a rapid turnaround time Point-of-Care (POC) Troponin T test with a higher sensitivity Elecsys TnT laboratory test, thus enabling medical institutions to deliver consistent and reliable results across hospital departments to support clinicians in their diagnosis of AMI.

Related Links:
Roche



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.